E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/10/2023 in the Prospect News Structured Products Daily.

New Issue: JPMorgan prices $1.19 million uncapped buffered return enhanced notes on two stocks

Chicago, Dec. 11 – JPMorgan Chase Financial Co. LLC priced $1.19 million of 0% uncapped buffered return enhanced notes due Nov. 5, 2024 linked to the stock performance of Zoetis Inc. and Thermo Fisher Scientific Inc., according to a 424B2 filing with the Securities and Exchange Commission.

If each stock gains, the payout at maturity will be par plus 1.66 times the return of the lesser-performing stock.

If either stock finishes flat or falls by up to 10%, the payout will be par.

If either stock falls by more than 10%, investors will lose 1% for every 1% that the lesser-performing stock declines beyond the buffer.

The notes are guaranteed by JPMorgan Chase & Co.

J.P. Morgan Securities LLC is the agent.

Issuer:JPMorgan Chase Financial Co. LLC
Guarantor:JPMorgan Chase & Co.
Issue:Uncapped buffered return enhanced notes
Underlying stocks:Zoetis Inc. and Thermo Fisher Scientific Inc.
Amount:$1,190,000
Maturity:Nov. 5, 2024
Coupon:0%
Price:Par
Payout at maturity:If each stock gains, par plus 1.66 times return of lesser-performing stock; par if either stock finishes flat or falls up to buffer; 1% loss for every 1% that lesser-performing stock declines beyond buffer
Initial levels:$150.78 for Zoetis, $513.97 for Thermo
Buffer levels:90% of initial levels
Strike date:Oct. 31, 2022
Pricing date:Nov. 1, 2022
Settlement date:Nov. 4, 2022
Agent:J.P. Morgan Securities LLC
Fees:0%
Cusip:48133PNT6

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.